BR112019022307A2 - Derivados da pirrolopirimidina úteis como inibidores de replicação de vírus da influenza. - Google Patents
Derivados da pirrolopirimidina úteis como inibidores de replicação de vírus da influenza. Download PDFInfo
- Publication number
- BR112019022307A2 BR112019022307A2 BR112019022307-0A BR112019022307A BR112019022307A2 BR 112019022307 A2 BR112019022307 A2 BR 112019022307A2 BR 112019022307 A BR112019022307 A BR 112019022307A BR 112019022307 A2 BR112019022307 A2 BR 112019022307A2
- Authority
- BR
- Brazil
- Prior art keywords
- patient
- pirrolopyrimidine
- virus replication
- derivatives useful
- replication inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
métodos para inibir a replicação de vírus da influenza em uma amostra biológica ou um paciente, para reduzir a quantidade de vírus da influenza em uma amostra biológica ou um paciente e para tratar influenza em um paciente compreendem administrar à referida amostra biológica ou ao paciente uma quantidade segura e eficaz de um composto representado por qualquer das fórmulas i-iii, ou um sal farmaceuticamente aceitável do mesmo. uma composição farmacêutica compreende uma quantidade segura e eficaz de tal composto ou sal farmaceuticamente aceitável do mesmo e um transportador, adjuvante ou veículo farmaceuticamente aceitável.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762489167P | 2017-04-24 | 2017-04-24 | |
US62/489,167 | 2017-04-24 | ||
PCT/US2018/028986 WO2018200425A1 (en) | 2017-04-24 | 2018-04-24 | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019022307A2 true BR112019022307A2 (pt) | 2020-05-26 |
Family
ID=62117141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019022307-0A BR112019022307A2 (pt) | 2017-04-24 | 2018-04-24 | Derivados da pirrolopirimidina úteis como inibidores de replicação de vírus da influenza. |
Country Status (19)
Country | Link |
---|---|
US (1) | US11014941B2 (pt) |
EP (1) | EP3615545B1 (pt) |
JP (1) | JP7165721B2 (pt) |
KR (1) | KR102598466B1 (pt) |
CN (1) | CN110637022B (pt) |
AU (1) | AU2018257778B2 (pt) |
BR (1) | BR112019022307A2 (pt) |
CA (1) | CA3059449A1 (pt) |
DK (1) | DK3615545T3 (pt) |
EA (1) | EA039181B1 (pt) |
ES (1) | ES2901875T3 (pt) |
IL (1) | IL269900B (pt) |
MX (1) | MX2019012759A (pt) |
NZ (1) | NZ757442A (pt) |
PH (1) | PH12019502376A1 (pt) |
PL (1) | PL3615545T3 (pt) |
SG (1) | SG11201909478UA (pt) |
TW (1) | TWI778052B (pt) |
WO (1) | WO2018200425A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2021004215A (es) * | 2018-10-17 | 2021-07-15 | Cocrystal Pharma Inc | Combinaciones de inhibidores de la replicación del virus de la gripe. |
AU2019380421A1 (en) * | 2018-11-13 | 2021-06-03 | Cocrystal Pharma, Inc. | Formulations of influenza therapeutics |
CN113748103A (zh) * | 2019-04-26 | 2021-12-03 | 日产化学株式会社 | 芳基磺酸酯化合物的制造方法 |
CN115698011B (zh) * | 2020-07-10 | 2023-10-20 | 四川海思科制药有限公司 | Pb2抑制剂及其制备方法和用途 |
WO2022109495A1 (en) * | 2020-11-23 | 2022-05-27 | The Regents Of The University Of California | Methods and compositions for linking rna stem loops |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB278965A (en) | 1927-03-24 | 1927-10-20 | Gerhard Haar | Improved agricultural plough |
US4093709A (en) | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4131648A (en) | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
US4180646A (en) | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
US4079038A (en) | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
CY1308A (en) | 1979-12-06 | 1985-12-06 | Glaxo Group Ltd | Device for dispensing medicaments |
US4304767A (en) | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
US4353656A (en) | 1980-10-14 | 1982-10-12 | Xerox Corporation | Moving coil, multiple energy print hammer system including a closed loop servo |
CY1492A (en) | 1981-07-08 | 1990-02-16 | Draco Ab | Powder inhalator |
US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
IE56059B1 (en) | 1982-10-08 | 1991-04-10 | Glaxo Group Ltd | Devices for administering medicaments to patients |
US4501729A (en) | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
US4753788A (en) | 1985-01-31 | 1988-06-28 | Vestar Research Inc. | Method for preparing small vesicles using microemulsification |
GR861995B (en) | 1985-07-30 | 1986-11-04 | Glaxo Group Ltd | Devices for administering medicaments to patients |
US4946931A (en) | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
DE69031279T2 (de) | 1989-12-05 | 1998-03-19 | Ramsey Foundation | Neurologische wirkstoffe zur nasalen verabreichung an das gehirn |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US5968543A (en) | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
US6596296B1 (en) | 1999-08-06 | 2003-07-22 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
US7252840B1 (en) | 1999-08-25 | 2007-08-07 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles |
US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
US6632666B2 (en) | 2000-01-14 | 2003-10-14 | Biolife Solutions, Inc. | Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media |
US6613355B2 (en) | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
WO2002013897A2 (en) | 2000-08-14 | 2002-02-21 | Advanced Inhalation Research, Inc. | Inhalation device and method |
AU2002230993B2 (en) | 2000-12-29 | 2006-02-02 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
US6848197B2 (en) | 2001-04-18 | 2005-02-01 | Advanced Inhalation Research, Inc. | Control of process humidity to produce large, porous particles |
WO2003015798A1 (en) | 2001-08-14 | 2003-02-27 | Toyama Chemical Co., Ltd. | Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue |
US6524606B1 (en) | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
DK1455755T3 (da) | 2001-11-20 | 2013-07-15 | Civitas Therapeutics Inc | Forbedrede partikelsammensætning til levering i lunge |
US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
US8001963B2 (en) | 2003-09-05 | 2011-08-23 | Kurve Technology, Inc. | Integrated nebulizer and particle dispersion chamber for nasal delivery of medicament to deep nasal cavity and paranasal sinuses |
RU2403252C2 (ru) | 2004-03-30 | 2010-11-10 | Вертекс Фармасьютикалз Инкорпорейтед | Азаиндолы, полезные в качестве ингибиторов jak и других протеинкиназ |
NZ601687A (en) | 2006-01-17 | 2014-03-28 | Vertex Pharma | Azaindoles useful as inhibitors of janus kinases |
RS57869B1 (sr) | 2009-06-17 | 2018-12-31 | Vertex Pharma | Inhibitori replikacije virusa gripa |
EP3351552B1 (en) | 2012-03-13 | 2021-05-19 | Gilead Sciences, Inc. | 2'-substituted carba-nucleoside analogs for antiviral treatment |
RS57541B1 (sr) * | 2013-11-13 | 2018-10-31 | Vertex Pharma | Postupci za pripremu inhibitora replikacije virusa gripa |
MX2017002972A (es) | 2014-09-08 | 2017-05-30 | Janssen Sciences Ireland Uc | Pirrolopirimidinas para usarse en la infeccion por el virus de la gripe. |
CN105524067A (zh) | 2014-09-28 | 2016-04-27 | 江苏柯菲平医药股份有限公司 | 4-取代吡咯并[2,3-d]嘧啶化合物及其用途 |
FR3039227B1 (fr) | 2015-07-22 | 2019-12-27 | Safran Aircraft Engines | Aeronef comprenant un propulseur arriere carene avec stator d’entree a volets mobiles |
SG11201804225PA (en) * | 2015-12-09 | 2018-06-28 | Sunshine Lake Pharma Co Ltd | Inhibitors of influenza virus replication, application methods and uses thereof |
WO2017133664A1 (en) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Bicyclic pyridine and pyrimidine derivatives and their use in the treatment, amelioration or prevention of influenza |
WO2017133667A1 (en) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Pyrimidine and pyridine derivatives and use in treatment, amelioration or prevention of influenza thereof |
WO2017198122A1 (zh) | 2016-05-19 | 2017-11-23 | 四川大学 | 抗流感小分子化合物及其制备方法和用途 |
DE102017000989A1 (de) * | 2017-02-03 | 2018-08-09 | Evonik Degussa Gmbh | Verfahren zur Herstellung von Cyclododecanon |
-
2018
- 2018-04-24 SG SG11201909478U patent/SG11201909478UA/en unknown
- 2018-04-24 PL PL18723298T patent/PL3615545T3/pl unknown
- 2018-04-24 TW TW107113876A patent/TWI778052B/zh active
- 2018-04-24 ES ES18723298T patent/ES2901875T3/es active Active
- 2018-04-24 NZ NZ757442A patent/NZ757442A/en unknown
- 2018-04-24 EA EA201992543A patent/EA039181B1/ru unknown
- 2018-04-24 MX MX2019012759A patent/MX2019012759A/es unknown
- 2018-04-24 BR BR112019022307-0A patent/BR112019022307A2/pt unknown
- 2018-04-24 DK DK18723298.8T patent/DK3615545T3/da active
- 2018-04-24 EP EP18723298.8A patent/EP3615545B1/en active Active
- 2018-04-24 US US16/603,951 patent/US11014941B2/en active Active
- 2018-04-24 JP JP2020507515A patent/JP7165721B2/ja active Active
- 2018-04-24 CN CN201880030665.3A patent/CN110637022B/zh active Active
- 2018-04-24 AU AU2018257778A patent/AU2018257778B2/en active Active
- 2018-04-24 WO PCT/US2018/028986 patent/WO2018200425A1/en unknown
- 2018-04-24 CA CA3059449A patent/CA3059449A1/en active Pending
- 2018-04-24 KR KR1020197033668A patent/KR102598466B1/ko active IP Right Grant
-
2019
- 2019-10-07 IL IL269900A patent/IL269900B/en unknown
- 2019-10-18 PH PH12019502376A patent/PH12019502376A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK3615545T3 (da) | 2021-11-22 |
WO2018200425A1 (en) | 2018-11-01 |
US11014941B2 (en) | 2021-05-25 |
MX2019012759A (es) | 2019-12-16 |
EP3615545A1 (en) | 2020-03-04 |
AU2018257778B2 (en) | 2022-02-17 |
KR102598466B1 (ko) | 2023-11-03 |
CA3059449A1 (en) | 2018-11-01 |
CN110637022A (zh) | 2019-12-31 |
IL269900B (en) | 2022-05-01 |
JP2020517738A (ja) | 2020-06-18 |
CN110637022B (zh) | 2022-09-16 |
EA201992543A1 (ru) | 2020-03-24 |
NZ757442A (en) | 2022-10-28 |
EA039181B1 (ru) | 2021-12-15 |
EP3615545B1 (en) | 2021-09-01 |
JP7165721B2 (ja) | 2022-11-04 |
SG11201909478UA (en) | 2019-11-28 |
TWI778052B (zh) | 2022-09-21 |
KR20190140971A (ko) | 2019-12-20 |
US20200123177A1 (en) | 2020-04-23 |
ES2901875T3 (es) | 2022-03-24 |
PL3615545T3 (pl) | 2022-01-10 |
AU2018257778A1 (en) | 2019-10-10 |
TW201839003A (zh) | 2018-11-01 |
PH12019502376A1 (en) | 2020-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112019022307A2 (pt) | Derivados da pirrolopirimidina úteis como inibidores de replicação de vírus da influenza. | |
CO2019013042A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
CO2019010295A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
ECSP18073366A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
BR112017023904A2 (pt) | derivados indol mono- ou dissubstituídos como inibidores da replicação viral da dengue | |
CO2019010292A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
ECSP18073293A (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue | |
CO2019012035A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
BR112017006299A2 (pt) | derivados indol mono- ou dissubstituídos como inibidores da replicação viral da dengue | |
ECSP18073245A (es) | Derivados de indol sustituidos como inhibidores de la replicación vírica del dengue | |
BR112017015123A2 (pt) | derivados de indol como inibidores da replicação viral do dengue | |
BR112018008601A2 (pt) | composições compreendendo o canabidiol e segundos agentes terapêuticos para o tratamento de câncer | |
BR112016027043A8 (pt) | combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer | |
BR112018006276A2 (pt) | composto, composição farmacêutica, e, inibidor de subunidade gyrb da dna girase e/ou subunidade pare de topoisomerase iv. | |
BR112019008698A2 (pt) | método para tratar câncer num sujeito que precisa do mesmo e composição farmacêutica | |
BR112017018977A2 (pt) | ?composto, composição farmacêutica, métodos para tratamento de uma infecção por hepatite c ou uma condição resultante de uma infecção por hepatite c, em um hospedeiro em necessidade do mesmo e para fabricação de um medicamento direcionado para uso terapêutico para tratamento de uma infecção pelo vírus da hepatite c, uso de um composto, e, formulação farmacêutica?. | |
EA201992295A1 (ru) | Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |